{
    "clinical_study": {
        "@rank": "141332", 
        "arm_group": [
            {
                "arm_group_label": "Laminaria", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this arm will receive laminaria cervical dilators one day before D&E procedure."
            }, 
            {
                "arm_group_label": "Dilapan-S", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this arm will receive Dilapan-S cervical dilators one day before D&E procedure."
            }
        ], 
        "brief_summary": {
            "textblock": "Primary objective: To study the difference in dilation and evacuation (D&E) procedure time\n      following overnight cervical preparation with laminaria or Dilapan-S\u2122. The investigators\n      hypothesize procedure time will be less with Dilapan-S\u2122.\n\n      Secondary objectives:  To compare the use of laminaria and Dilapan-S\u2122 for differences in:\n      (1) initial cervical dilation before D&E; (2) need for mechanical dilation to accomplish D&E\n      and ease of dilation if required; (3) number of osmotic dilators placed; (4) ability to\n      complete the D&E procedure without further cervical preparation; (5) complications; (6) pain\n      and other side effects; (7) patient acceptability; and (8) provider acceptability."
        }, 
        "brief_title": "Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation", 
        "condition": "Second Trimester Abortion", 
        "condition_browse": {
            "mesh_term": "Dilatation, Pathologic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age and older\n\n          -  Seeking pregnancy termination from 18 0/7 to 24 0/7 weeks of gestation\n\n          -  Eligible for pregnancy termination at Planned Parenthood of New York City\n\n          -  Able to give informed consent\n\n          -  English speaking\n\n        Exclusion Criteria:\n\n          -  \u2022 Active bleeding or hemodynamically unstable at enrollment\n\n               -  Signs of chorioamnionitis or clinical infection at enrollment\n\n               -  Signs of spontaneous labor or cervical insufficiency at enrollment\n\n               -  Spontaneous intrauterine fetal demise\n\n               -  Allergy to laminaria or Dilapan-S\u2122"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033083", 
            "org_study_id": "laminariavsdilapan"
        }, 
        "intervention": [
            {
                "arm_group_label": "Laminaria", 
                "intervention_name": "Laminaria", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Dilapan-S", 
                "intervention_name": "Dilapan-S", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "abortion", 
            "cervical dilation"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10012"
                }, 
                "name": "Planned Parenthood of New York City"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: A Randomized Controlled Trial", 
        "overall_contact": {
            "email": "cti@ppnyc.org", 
            "last_name": "Program Director of Clinical Research", 
            "phone": "212-274-7255"
        }, 
        "overall_official": {
            "affiliation": "Planned Parenthood of New York City", 
            "last_name": "Principal Investigator", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "D&E procedure time", 
            "safety_issue": "No", 
            "time_frame": "The primary outcome measure will be assessed on the day of the patient's D&E procedure. (day 2)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033083"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Planned Parenthood of New York City, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Society of Family Planning", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Planned Parenthood of New York City, Inc.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}